Thank you, Mr. Chair.
It's very interesting to hear what our witnesses are telling us this evening as part of this study. I think many of us have known people who have had breast cancer. I would like to take a moment to remember Nathalie, a friend who was diagnosed with breast cancer several years ago. She was in her late forties, and she passed away a few years later, just in her early fifties.
This cancer affects far too many women and takes them away from us far too soon. This brings me to the whole issue of screening and treatment.
Dr. Narod, you mentioned a study in Great Britain. That's interesting. A lot of questions have been asked by my colleagues about age and national guidelines, but what's happening internationally?
Mr. Simard, you are part of an international research group, so I invite you to comment on that as well. What could we learn from the work being done internationally?
Dr. Gordon, in your brief, you talk about statistics and data from other countries. What can these studies that are done elsewhere bring us here?